US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 10.790
  • -0.540-4.77%
Close Dec 18 16:00 ET
  • 11.990
  • +1.200+11.12%
Pre 04:55 ET
455.33MMarket Cap-3.57P/E (TTM)

UroGen Pharma Ltd Key Stats

UroGen Pharma Ltd Q3 2024 Earnings Date

Currency:USDNov 6, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
24.20M
25.20M
+999.71K
Beat Est.
+16.08%
+20.87%
+4.13%
EPS
-0.81
-0.55
+0.26
Beat Est.
-19.86%
+19.12%
+32.51%
Strong Buy

Nov 30, 2024

UroGen Pharma Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 21.600M--
--2024/Q4-- / 26.133M--
Nov 6, 20242024/Q325.204M / 24.204M--
Aug 13, 20242024/Q221.848M / 23.963M--
May 13, 20242024/Q118.781M / 21.391M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 21.600M--
--2024/Q4-- / 26.133M--
Nov 6, 20242024/Q325.204M / 24.204M--
Aug 13, 20242024/Q221.848M / 23.963M--
May 13, 20242024/Q118.781M / 21.391M--

Unlock Free Earnings Estimates

UroGen Pharma Ltd Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data